|
US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
EP2597087B1
(en)
|
2005-10-25 |
2016-03-30 |
Shionogi&Co., Ltd. |
Dihydrooxazine and tetrahydropyrimidine derivatives as BACE 1 inhibitors
|
|
EP2147914B1
(en)
*
|
2007-04-24 |
2014-06-04 |
Shionogi&Co., Ltd. |
Aminodihydrothiazine derivatives substituted with cyclic groups
|
|
JP5383483B2
(ja)
|
2007-04-24 |
2014-01-08 |
塩野義製薬株式会社 |
アルツハイマー症治療用医薬組成物
|
|
AU2009205072C1
(en)
|
2008-01-18 |
2016-10-13 |
Eisai R & D Management Co., Ltd. |
Condensed aminodihydrothiazine derivative
|
|
CA2727859C
(en)
|
2008-06-13 |
2016-11-01 |
Shionogi & Co., Ltd. |
SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ß-SECRETASE-INHIBITING ACTIVITY
|
|
CN102105475B
(zh)
*
|
2008-07-28 |
2014-04-09 |
卫材R&D管理有限公司 |
螺氨基二氢噻嗪衍生物
|
|
US8198269B2
(en)
*
|
2008-09-30 |
2012-06-12 |
Eisai R&D Management Co., Ltd. |
Fused aminodihydrothiazine derivative
|
|
JPWO2010047372A1
(ja)
|
2008-10-22 |
2012-03-22 |
塩野義製薬株式会社 |
Ｂａｃｅ１阻害活性を有する２−アミノピリミジン−４−オンおよび２−アミノピリジン誘導体
|
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
|
WO2011044187A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
US8569310B2
(en)
|
2009-10-08 |
2013-10-29 |
Merck Sharp & Dohme Corp. |
Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions and their use
|
|
US8557826B2
(en)
|
2009-10-08 |
2013-10-15 |
Merck Sharp & Dohme Corp. |
Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions, and their use
|
|
US20120245155A1
(en)
*
|
2009-12-11 |
2012-09-27 |
Shionogi & Co., Ltd. |
Fused heterocyclic compound having amino group
|
|
ES2590038T5
(es)
|
2009-12-11 |
2021-10-19 |
Shionogi & Co |
Derivado de oxazina
|
|
US20130109683A1
(en)
|
2010-06-09 |
2013-05-02 |
Janssen Pharmaceutica Nv |
5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
|
|
AU2011321427A1
(en)
|
2010-10-29 |
2013-05-02 |
Shionogi & Co., Ltd. |
Naphthyridine derivative
|
|
JP5766198B2
(ja)
|
2010-10-29 |
2015-08-19 |
塩野義製薬株式会社 |
縮合アミノジヒドロピリミジン誘導体
|
|
JP5834091B2
(ja)
|
2010-12-22 |
2015-12-16 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ |
ベータ−セクレターゼ（ＢＡＣＥ）の阻害剤として有用な５，６−ジヒドロ−イミダゾ［１，２−ａ］ピラジン−８−イルアミン誘導体
|
|
GB201100181D0
(en)
*
|
2011-01-06 |
2011-02-23 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
GB201101139D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
EP2665716B1
(en)
*
|
2011-01-21 |
2017-03-08 |
Eisai R&D Management Co., Ltd. |
Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives
|
|
GB201101140D0
(en)
|
2011-01-21 |
2011-03-09 |
Eisai Ltd |
Fused aminodihydrothiazine derivatives
|
|
KR102012675B1
(ko)
|
2011-03-09 |
2019-08-21 |
얀센 파마슈티카 엔.브이. |
베타-세크레타제(BACE)의 억제제로서 유용한 3,4-디하이드로-피롤로[1,2-a]피라진-1-일아민 유도체
|
|
EP2694521B1
(en)
|
2011-04-07 |
2015-11-25 |
Merck Sharp & Dohme Corp. |
Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
US9221839B2
(en)
|
2011-04-07 |
2015-12-29 |
Merck Sharp & Dohme Corp. |
C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
|
|
TW201247635A
(en)
|
2011-04-26 |
2012-12-01 |
Shionogi & Co |
Oxazine derivatives and a pharmaceutical composition for inhibiting BAC1 containing them
|
|
US8604024B2
(en)
|
2011-05-24 |
2013-12-10 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
|
WO2012162334A1
(en)
|
2011-05-24 |
2012-11-29 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
|
US8927535B2
(en)
|
2011-07-06 |
2015-01-06 |
Hoffman-La Roche Inc. |
Cyclopropyl-fused-1,3-thiazepines as BACE1 and/or BACE2 inhibitors
|
|
JP2014524472A
(ja)
|
2011-08-22 |
2014-09-22 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Ｂａｃｅ阻害剤としての２−スピロ置換イミノチアジンならびにそのモノオキシドおよびジオキシド、組成物、ならびにそれらの使用
|
|
EP2751116B1
(en)
|
2011-08-31 |
2016-10-12 |
Pfizer Inc |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
|
|
JO3143B1
(ar)
|
2012-04-03 |
2017-09-20 |
Lilly Co Eli |
مركبات تتراهيدرو بيرولو ثيازين
|
|
EP2841423B1
(en)
|
2012-04-27 |
2016-11-30 |
Eisai R&D Management Co., Ltd. |
Method for producing 5-(difluoromethyl)pyrazine-2-carboxilic acid and production intermediate thereof
|
|
JP6110937B2
(ja)
|
2012-05-04 |
2017-04-05 |
ファイザー・インク |
ＡＰＰ、ＢＡＣＥ１、およびＢＡＣＥ２の阻害剤としての複素環式置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
GB201212871D0
(en)
|
2012-07-20 |
2012-09-05 |
Eisai Ltd |
Novel compounds
|
|
WO2014045162A1
(en)
|
2012-09-20 |
2014-03-27 |
Pfizer Inc. |
ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-ANIME COMPOUNDS
|
|
US9540359B2
(en)
|
2012-10-24 |
2017-01-10 |
Shionogi & Co., Ltd. |
Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity
|
|
EP2912041B1
(en)
*
|
2012-10-26 |
2016-12-14 |
Eli Lilly and Company |
Tetrahydropyrrolothiazine derivatives as bace inhibitors
|
|
EP2931731A1
(en)
|
2012-12-11 |
2015-10-21 |
Pfizer Inc. |
Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
|
|
WO2014098831A1
(en)
|
2012-12-19 |
2014-06-26 |
Bristol-Myers Squibb Company |
4,6-diarylaminothiazines as bace1 inhibitors and their use for the reduction of beta-amyloid production
|
|
JP6162820B2
(ja)
|
2012-12-19 |
2017-07-12 |
ファイザー・インク |
炭素環式および複素環式置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
|
|
US9309263B2
(en)
|
2013-01-29 |
2016-04-12 |
Amgen Inc. |
Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof
|
|
ES2769578T3
(es)
|
2013-02-12 |
2020-06-26 |
Buck Inst Res Aging |
Hidantoínas que modulan el procesamiento de APP mediado por BACE
|
|
CA2897678A1
(en)
|
2013-02-13 |
2014-08-21 |
Pfizer Inc. |
Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
US9233981B1
(en)
|
2013-02-15 |
2016-01-12 |
Pfizer Inc. |
Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
|
|
CA2902212C
(en)
*
|
2013-03-01 |
2020-10-13 |
Amgen Inc. |
Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
JP6374889B2
(ja)
|
2013-03-08 |
2018-08-15 |
アムジエン・インコーポレーテツド |
β−セクレターゼ阻害剤としての過フッ素化シクロプロピル縮合１，３−オキサジン−２−アミン化合物、及び使用方法
|
|
TWI593692B
(zh)
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
|
WO2014198854A1
(en)
|
2013-06-12 |
2014-12-18 |
Janssen Pharmaceutica Nv |
4-amino-6-phenyl-6,7-dihydro[1,2,3]triazolo[1,5-a]pyrazine derivatives as inhibitors of beta-secretase (bace)
|
|
MX368326B
(es)
|
2013-06-12 |
2019-09-27 |
Janssen Pharmaceutica Nv |
Derivados de 4-amino-6-fenil-5,6-dihidroimidazo[1,5-a]pirazin-3(2h )-ona como inhibidores de beta-secretasa (bace).
|
|
TWI639607B
(zh)
*
|
2013-06-18 |
2018-11-01 |
美國禮來大藥廠 |
Ｂａｃｅ抑制劑
|
|
WO2015017407A1
(en)
|
2013-07-30 |
2015-02-05 |
Amgen Inc. |
Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta- secretase
|
|
MD20160105A2
(ro)
|
2014-04-10 |
2017-03-31 |
Pfizer Inc. |
2-Amino-6-metil-4,4a,5,6-tetrahidropirano[3,4-d][1,3]tiazin-8a(8H)-il-1,3-tiazol-4-il amide
|
|
CN106795147B
(zh)
|
2014-08-08 |
2020-09-22 |
美国安进公司 |
作为β-分泌酶抑制剂的环丙基稠合噻嗪-2-胺化合物和使用方法
|
|
MA40941A
(fr)
|
2014-11-10 |
2017-09-19 |
H Lundbeck As |
2-amino-5,5-difluoro-6-(fluorométhyl)-6-phényl-3,4,5,6-tétrahydropyridines comme inhibiteurs de bace1
|
|
CR20170187A
(es)
|
2014-11-10 |
2018-02-01 |
H Lundbeck As |
2-Amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de BACE1 para el tratamiento de la enfermedad de Alzheimer
|
|
JO3458B1
(ar)
|
2014-11-10 |
2020-07-05 |
H Lundbeck As |
2- أمينو-6- (دايفلوروميثيل) – 5، 5- ديفلورو-6-فينيل-3،4، 5، 6-تيتراهيدروبيريدين كمثبطات bace1
|
|
ES2768823T3
(es)
|
2014-12-18 |
2020-06-23 |
Janssen Pharmaceutica Nv |
Derivados de 2,3,4,5-tetrahidropiridin-6-amina y 3,4-dihidro-2H-pirrol-5-amina útiles como inhibidores de beta-secretasa
|
|
AR103680A1
(es)
|
2015-02-23 |
2017-05-24 |
Lilly Co Eli |
Inhibidores selectivos de bace1
|
|
EP3271356B1
(en)
*
|
2015-03-19 |
2019-10-16 |
Eli Lilly and Company |
Selective bace1 inhibitors
|
|
AR104241A1
(es)
|
2015-04-29 |
2017-07-05 |
Lilly Co Eli |
Derivados de tetrahidrofuro tiazina como inhibidores de bace1 selectivos
|
|
WO2017024180A1
(en)
|
2015-08-06 |
2017-02-09 |
Amgen Inc. |
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
|
|
TW201717948A
(zh)
|
2015-08-10 |
2017-06-01 |
Ｈ 朗德貝克公司 |
包括給予２－胺基－３，５，５－三氟－３，４，５，６－四氫吡啶的聯合治療
|
|
TW201718543A
(zh)
|
2015-08-12 |
2017-06-01 |
Ｈ 朗德貝克公司 |
作爲ｂａｃｅ１抑制劑之２－胺基－３－氟－３－（氟甲基）－６－甲基－６－苯基－３，４，５，６－四氫吡啶
|
|
JP2018527338A
(ja)
*
|
2015-08-12 |
2018-09-20 |
ハー・ルンドベック・アクチエゼルスカベット |
ＢＡＣＥ１阻害剤としての２−アミノ−７ａ−フェニル−３，４，４ａ，５，７，７ａ−ヘキサヒドロフロ［３，４−ｂ］ピリジン
|
|
JP2018531923A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
Ｎ−［２−（２−アミノ−６，６−二置換−４，４ａ，５，６−テトラヒドロピラノ［３，４−ｄ］［１，３］チアジン−８ａ（８Ｈ）−イル）−１，３−チアゾール−４−イル］アミド
|
|
JP2018534251A
(ja)
|
2015-09-24 |
2018-11-22 |
ファイザー・インク |
Ｂａｃｅ阻害剤として有用なｎ−［２−（３−アミノ−２，５−ジメチル−１，１−ジオキシド−５，６−ジヒドロ−２ｈ−１，２，４−チアジアジン−５−イル）−１，３−チアゾール−４−イル］アミド
|
|
JP2018531924A
(ja)
|
2015-09-24 |
2018-11-01 |
ファイザー・インク |
テトラヒドロピラノ［３，４−ｄ］［１，３］オキサジン誘導体、およびｂａｃｅ阻害剤としてのその使用
|
|
TWI675034B
(zh)
*
|
2016-05-20 |
2019-10-21 |
美商美國禮來大藥廠 |
四氫呋喃并<img align="absmiddle" height="18px" width="27px" file="d10999.TIF" alt="其他非圖式 ed10999.png" img-content="tif" orientation="portrait" inline="yes" giffile="ed10999.png"></img>化合物及其作為選擇性ＢＡＣＥ１抑制劑之用途
|
|
EP3535271A1
(en)
|
2016-11-04 |
2019-09-11 |
Janssen Pharmaceutica NV |
4,4a,5,7-tetrahydro-3h-furo[3,4-b]pyridinyl compounds
|
|
MX2019007100A
(es)
|
2016-12-15 |
2019-12-16 |
Amgen Inc |
Derivados de tiazina y oxazina biciclicos como inhibidores de beta-secretasa y metodos de uso.
|
|
JP7177773B2
(ja)
|
2016-12-15 |
2022-11-24 |
アムジエン・インコーポレーテツド |
β－セクレターゼ阻害剤としてのオキサジン誘導体および使用方法
|
|
MX2019007102A
(es)
|
2016-12-15 |
2019-12-16 |
Amgen Inc |
Derivados de tiazina como inhibidores de beta-secretasa y metodos de uso.
|
|
AU2017378316B2
(en)
|
2016-12-15 |
2021-04-01 |
Amgen Inc. |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
|
|
MX2019007104A
(es)
|
2016-12-15 |
2019-11-05 |
Amgen Inc |
Derivados de dioxido de 1,4-tiazina y dioxido de 1,2,4-tiadiazina como inhibidores de beta-secretasa y metodos de uso.
|
|
CA3051779A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
WO2018162443A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
WO2018162445A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
US20210284659A1
(en)
*
|
2017-03-07 |
2021-09-16 |
Janssen Pharmaceutica Nv |
Inhibitors of beta secretase
|
|
MA47729A
(fr)
*
|
2017-03-07 |
2020-01-15 |
Janssen Pharmaceutica Nv |
Inhibiteurs de bêta-sécrétase
|
|
EA201992108A1
(ru)
*
|
2017-09-07 |
2020-01-27 |
Янссен Фармацевтика Нв |
Ингибиторы бета-секретазы
|
|
CN110590517A
(zh)
*
|
2019-09-24 |
2019-12-20 |
武汉嘉诺康医药技术有限公司 |
一种3，4-二羟基-2′-氯苯乙酮的制备方法
|
